SINTX Technologies (Nasdaq: SINT) develops and manufactures advanced silicon nitride ceramics for medical and other high-value applications. Our proprietary material platform offers exceptional strength, biocompatibility, and antibacterial properties, positioning SINTX as a leader in high-performance technical ceramics.
Our corporate headquarters and manufacturing facility are located in Salt Lake City, Utah, USA.
SINTX Technologies common stock trades on the Nasdaq Capital Market under the ticker symbol SINT.
SINTX shares can be purchased through any licensed broker or online trading platform under the ticker symbol SINT.
SINTX does not currently pay dividends and does not offer a dividend reinvestment plan at this time. The company intends to retain earnings for reinvestment in growth and innovation initiatives.
Our transfer agent handles shareholder records, stock transfers, and lost or replacement certificates.
Transfer Agent: Equiniti Trust Company, LLC (often shown as “Equiniti” or “EQ”)
Website: https://equiniti.com/us/
Phone (U.S.): 1-800-937-5449
Mailing Address: 6201 15th Avenue, Brooklyn, NY 11219
Our fiscal year ends on December 31.
All SEC filings, including annual (Form 10-K), quarterly (Form 10-Q), and current reports (Form 8-K), are available in the “SEC Filings” section of our Investor Relations website or directly on the SEC’s EDGAR database at www.sec.gov.
You can subscribe to email alerts for press releases, financial results, and other investor updates through the “Email Alerts” section of our Investor Relations website.
Biographies for our executive leadership and board members are available on the “Corporate Governance” section of our Investor Relations site.
For investor inquiries, please contact:
Investor Relations
Email: IR@sintx.com